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Local staging of sigmoid colon
cancer using MRI
Claus Dam1, Jan Lindebjerg1, Anders Jakobsen1,2,
Lars Henrik Jensen1,2, Hans Rahr1,2 and
Søren Rafael Rafaelsen1,2
Abstract
Background: An accurate radiological staging of colon cancer is crucial to select patients who may benefit from
neoadjuvant chemotherapy.
Purpose: To evaluate the diagnostic accuracy of preoperative magnetic resonance imaging (MRI) in identifying locally
advanced sigmoid colon cancer, poor prognostic factors, and the inter-observer variation of the tumor apparent diffusion
coefficient (ADC) values of diffusion-weighted imaging (DWI).
Material and Methods: Using 1.5 T MRI with high resolution T2-weighted (T2W) imaging, DWI, and no contrast
enhancement, 35 patients with sigmoid colon cancer were assessed. T-stage, N-stage, extramural vascular invasion
(EMVI), and ADC values of the tumors were assessed and blindly compared by two observers using postoperative
histopathological examination as the gold standard. Early tumors were defined as T1 to T3ab, and advanced tumors as
T3cd or T4.
Results: The accuracy of the two radiologists in staging early versus advanced tumors, N-stage, and identification of
EMVI was 94%/89%, 60%/66%, and 77%/60% with an inter-observer agreement of i¼ 0.86 (95% confidence interval
[CI]¼ 0.67–1.00), i¼ 0.64 (95% CI¼ 0.39–0.90), and i¼ 0.52 (95% CI¼ 0.23–0.80). All the measured mean ADC
values were below 1.0 103 mm2/s with an intra-class correlation coefficient in T3cd–T4 tumors of 0.85.
Conclusion: Preoperative MRI can identify locally advanced sigmoid colon cancer and has potential as the imaging of
choice to select patients for neoadjuvant chemotherapy. Initial experience with ADC measurement was achieved with an
excellent inter-observer agreement in advanced tumors.
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Introduction
Colorectal cancer is associated with signiﬁcant morbid-
ity and mortality and is one of the most common
types of cancer in the developed countries (1). With
an increasing age of the population, colorectal cancer
will also in the years to come represent a considerable
burden to the individual patient and to the healthcare
system. The only curative treatment is radical resection,
but even if this is performed, locally advanced colon
cancer has a poor prognosis. Progress in treatment is
therefore of utmost importance and surgery combined
with other treatment modalities may improve the out-
come. Preoperative (neoadjuvant) chemotherapy is
eﬀective in a number of advanced gastrointestinal can-
cers, including rectal cancer, and has shown promising
results in the ﬁrst trials on locally advanced colon
cancer (2–4). Preoperative imaging is essential in iden-
tifying patients with locally advanced colon cancer at
high risk of relapse and therefore candidates for
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neoadjuvant therapy. Contrast-enhanced multi-detec-
tor computed tomography (MDCT) is currently the
standard modality for preoperative local staging of
colon cancer and has shown a reasonable accuracy
in discriminating between locally and non-locally
advanced colon cancer (5,6). In rectal cancer, magnetic
resonance imaging (MRI) is well established for pre-
operative local staging (7) and recent studies have sug-
gested that MRI may also have an advantage over CT
in precise local staging of colon cancer (8,9). Functional
MRI sequences such as diﬀusion-weighted imaging
(DWI) are increasingly applied to provide additional
quantitative characterization of the tumors before,
during, and after chemotherapy expressed by the
tumor’s apparent diﬀusion coeﬃcient (ADC) values
(10). The reproducibility of ADC values among obser-
vers is therefore important to evaluate.
The aims of this study were, ﬁrst, to evaluate the
diagnostic accuracy of preoperative MRI in identifying
locally advanced sigmoid colon cancer and poor prog-
nostic factors and, second, to gain an initial experience
with measuring of tumor ADC values on DWI by
determining the inter-observer variability.
Material and Methods
The study was approved by the Danish Data Protection
Agency. During the years 2010–2015, 331 patients
underwent elective operation for a carcinoma in the
sigmoid colon at the Department of Surgery, Vejle
Hospital. By retrospectively reviewing our Radiology
Information System (RIS)-Picture Archiving and
Communications System (PACS) we identiﬁed 41 out
of the 331 patients as having a preoperative MRI of the
lower abdomen/pelvis performed. In six of these
patients, however, DW sequences had not been per-
formed. A total of 35 patients with a complete pre-
operative MRI were thus included in the study, none
of which were treated with neoadjuvant therapy.
The MRI scans were carried out using an Ingenia
1.5 T MRI unit release 4.1.3.3 with a 32-channel Philips
dStream Torso coil over the pelvis (Philips Medical
Systems, Best, The Netherlands). After localizer
scans, fast T2-weighted (T2W) spin-echo sequences
were obtained. The scan included 3-mm axial slices at
a 90 angle to the tumor, and the axial scans were pre-
pared by the MRI radiographer assisted by a radiolo-
gist to ensure perpendicular images. No contrast
enhancement was used. DWI was performed perpen-
dicular to the tumor using an echo planar imaging
(EPI) factor of 61. Five diﬀerent b values (strength
and timing of the gradients to generate DWI) were
used applying diﬀusion-sensitive gradients; b¼ 0,
b¼ 200, b¼ 400, b¼ 600, and b¼ 800 s/mm2. The ﬁrst
series was a set of image sequences formed by
echo-planar spin-echo T2W imaging (b¼ 0). The next
series formed gradients at the x, y, and z directions and
formed isotropic images obtained by calculating diﬀu-
sion vector projections of the three directions. ADC
maps of the isotropic images were created automatic-
ally by the Philips Ingenia software. Patients were
scanned in the supine position. Bowel cleansing was
not performed and no oral or rectal contrast media
was administered.
All images were evaluated using an Easyviz Impax
PACS (Picture Archive Communication System) work-
station (Medical Insight, Valby, Denmark) with a moni-
tor (1600 1200 pixels), Megapixels Diagnostic Display
System, Coronis (Barco, Kortijk, Belgium). ADC maps
in grayscale were automatically generated by the Philips
system using a mono-exponential decay model.
The MRI scans were retrospectively assessed by two
independent observers, i.e. observer 1 was a senior resi-
dent in radiology and observer 2 was an experienced
gastrointestinal radiologist. Additionally, the observers
were blinded to one another, results of other imaging,
the pathology reports, and clinical data apart from the
endoscopic ﬁndings of tumor location. The observers
recorded the tumor size, T-stage, extent of extramural
tumor invasion (ETI), presence of metastatic lymph
nodes, presence of extramural vascular invasion
(EMVI), and ADC value of the tumors.
Size was reported as the largest tumor diameter in
one of the perpendicular planes. T-stage assessed by
MRI was evaluated according to the TNM system.
ETI was deﬁned as maximal tumor outgrowth from
the intestinal wall in millimeters. T4 tumors and T3
tumors with more than 5mm ETI (T3cd–T4) were clas-
siﬁed as locally advanced and T1, T2, and T3 tumors
with ETI 5mm or less were classiﬁed as early (i.e. non-
locally advanced). Regional lymph nodes, regardless of
metastatic status, were detected using both T2W and
DWI sequences. After detection, the lymph nodes with
size (short axis) alone 10mm or with size (short axis)
>5mm combined with an irregular border and/or
inhomogeneous signal intensity on T2 images were
deﬁned as metastatic. EMVI was considered present if
the tumor invaded a pericolic vessel. ADC values were
reported as the mean ADC acquired by manually draw-
ing of a precise region of interest (ROI) on the ADC
map delineating the most restrictive part of the solid
tumor on a single slice, avoiding intraluminal air.
Surgery was performed within a median of 12 days
(range¼ 1–23 days) after the MRI. The resected speci-
mens were transferred to the Department of Pathology
and ﬁxed for two days in neutral, buﬀered formalin.
After ﬁxation, all tumors were sliced transversally.
The tumor size and deepest penetration from the
outer edge of tunica muscularis were measured on the
slices and conﬁrmed microscopically.
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The resected specimens were classiﬁed according to
the pTNM system (11) by an experienced gastrointes-
tinal pathologist. The peritoneal surface was considered
involved (pT4) if viable cancer was detected outside the
peritoneal lining or inﬁltrating adjacent organs. The
pathologist was blinded to the MRI ﬁndings.
A complete postoperative histopathological examin-
ation was regarded as the end-point.
Statistical analysis
All patients had an evaluable MRI and histopathology
report for statistical analysis. Data were entered into
the Number Cruncher Statistical System software
(NCSS), (Kaysville, UT, USA). Descriptive statistics
were applied. Sensitivity, speciﬁcity, and accuracy
with 95% conﬁdence intervals (CI) were calculated. A
P value< 0.05 was considered to indicate a statistically
signiﬁcant diﬀerence. Comparison of proportions was
performed using the X2 test or, when appropriate,
Fisher’s exact test. Unweighted Cohen’s Kappa coeﬃ-
cients (k) for categorical outcomes were calculated for
inter-observer comparison and categorized as poor,
fair, moderate, good, and very good agreement accord-
ing to Kappa (k) values< 0.20, 0.21–0.40, 0.41–0.60,
0.61–0.80, and 0.81–1.00, respectively. Inter-observer
variability in relation to tumor ADC measurements
was analyzed by calculating the intra-class correlation
coeﬃcient (ICC) (0.00–0.20¼ poor, 0.21–0.40¼ fair,
0.41–0.59¼moderate, 0.60–0.74¼ good, and 0.75–
1.00¼ excellent).
Results
The study population included 35 patients with histo-
pathology veriﬁed sigmoid colon cancer. The mean age
was 70 years (range¼ 47–83 years). Twenty-one
patients (60%) were male. All patients had one tumor
in the sigmoid colon with a mean size of 3.6 cm
(range¼ 1.7–7.0 cm) measured at the ﬁnal pathological
examination. The ﬁnal histopathological ﬁndings
revealed ten patients (29%) with metastatic lymph
nodes and nine (26%) with EMVI.
The correlation between observer staging of the
tumors by MRI as early or advanced and histopatho-
logical classiﬁcation is shown in Table 1. The overall
accuracy of the two observers in identifying locally
advanced colon cancer was 94% and 89% using hist-
ology as the gold standard. The sensitivity of both
observers was 89% (95% CI¼ 51–99). The speciﬁcity
was 96% (95% CI¼ 78–100) for observer 1 and 88%
(95% CI¼ 69–97) for observer 2. The inter-observer
agreement in staging the tumors as early or advanced
was very good with a Cohen kappa value of k¼ 0.86
(95% CI¼ 0.67–1.00). The correlation between the
identiﬁcation of lymph node involvement assessed by
MRI for each observer and histopathology is shown in
Table 2. The overall accuracy of the two observers
compared with histology in identifying nodal involve-
ment was 60% and 66%. The sensitivity of both obser-
vers was 90% (95% CI¼ 54–99). The speciﬁcity of
observer 1 was 48% (95% CI¼ 28–68) and 56%
(95% CI¼ 35–75) for observer 2. The inter-observer
agreement as to identiﬁcation of nodal involvement
was good with a Cohen kappa value of k¼ 0.64 (95%
CI¼ 0.39–0.90).
The correlation between histopathology and extra-
mural vascular invasion found on MRI by each obser-
ver is shown in Table 3. The overall accuracy of the two
observers in identifying EMVI based on tumor invasion
Table 1. Summary statistics of identifying locally advanced
tumors by MRI.
MRI
Observer 1 Observer 2
T1–T3ab* T3cd–T4y T1–T3ab* T3cd–T4y
Pathology
T1–T3ab 25 1 23 3
T3cd–T4 1 8 1 8
*Non-locally advanced tumors: T1, T2, or T3 tumor with an extramural
tumor invasion <5 mm.
yLocally advanced tumors: T3 with extramural tumor invasion 5 mm or
T4 tumor.
Observer 1: accuracy¼ 94%, sensitivity¼ 89% (51–99%), specifi-
city¼ 96% (78–100%), positive predictive value (PPV)¼ 89% (51–99%),
negative predictive value (NPV) 96% (78–100%).
Observer 2: accuracy¼ 89%, sensitivity¼ 89% (51–99%), specifi-
city¼ 88% (69–97%), PPV¼ 89% (51–99%), NPV¼ 88% (69–97%).
Inter-observer agreement: Kappa¼ 0.86 (0.67–1.00).
Table 2. Summary statistics of lymph node involvement by MRI.
MRI
Observer 1 Observer 2
N0* Nþy N0* Nþy
Pathology
N0 12 13 14 11
Nþ 1 9 1 9
*No lymph nodes >10 mm or >5 mm with an irregular border/inhomo-
geneous signal intensity.
yN1 or greater.
Observer 1: accuracy¼ 60%, sensitivity¼ 90% (54–99%), specificity¼
48% (28–68%).
Observer 2: accuracy¼ 66%, sensitivity¼ 90% (54–95%), specificity¼
56% (35–75%).
Inter-observer agreement: Kappa¼ 0.64 (0.39–0.90).
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in a pericolic vessel was 77% and 60% compared with
histological examination. The sensitivity and speciﬁcity
for observer 1 was 67% (95% CI¼ 31–91) and 81%
(95% CI¼ 60–93), respectively, and for observer 2 it
was 56% (95% CI¼ 23–85) and 62% (95% CI¼ 41–
79), respectively. The inter-observer agreement in
EMVI identiﬁcation was moderate with a Cohen
kappa value of k¼ 0.52 (95% CI¼ 0.23–0.80).
ADC measurement could be performed in all
patients and the mean ADC in all tumors showed
values below 1.0 103 mm2/s. The ICC between the
two observers using single slice ROIs on the DWI MRI
for both early and advanced tumors was moderate to
good (ICC¼ 0.60), whereas the ICC for advanced
tumors only was excellent (ICC¼ 0.85). A subgroup
analysis showed no signiﬁcant diﬀerence of the mea-
sured mean ADC values (103 mm2/s) in the pathol-
ogy-based categories of local tumor: T1–T3ab (n¼ 26)
versus T3cd–T4 (n¼ 9), 0.74 (95% CI¼ 0.68–0.79)
versus 0.70 (95% CI¼ 0.61–0.80); node status: node-
negative (n¼ 25) versus node-positive (n¼ 10), 0.72
(95% CI¼ 0.60–0.77) versus 0.75 (95% CI¼ 0.65–
0.84); and EMVI status: EMVI-negative (n¼ 26)
versus EMVI-positive (n¼ 9), 0.72 (95% CI¼ 0.67–
0.78) versus 0.74 (95% CI¼ 0.65–0.84) in observer 1
or observer 2; 0.63 (95% CI¼ 0.55–0.70) versus 0.67
(95% CI¼ 0.54–0.80), 0.63 (95% CI¼ 0.55–0.70)
versus 0.67 (95% CI¼ 0.52–0.81), and 0.64 (95%
CI¼ 0.56–0.72) versus 0.63 (95% CI¼ 0.52–0.74)
respectively.
Discussion
An accurate radiological staging of colon cancer is cru-
cial to select patients with locally advanced tumors at
high risk of relapse who may beneﬁt from preoperative
chemotherapy (12).
This study aimed to determine the diagnostic accur-
acy of preoperative MRI in identifying locally
advanced sigmoid colon cancer and poor prognostic
factors with postoperative histopathologic ﬁndings as
the gold standard. Also, we wanted to evaluate the
inter-observer agreement of the ADC values of the
tumors on DWI.
The results showed that MRI is able to detect locally
advanced sigmoid colon cancer deﬁned as T3cd–T4
tumors. The accuracy of MRI in relation to the two
observers in identifying locally advanced sigmoid
colon cancer was very good at 94% and 89%, respect-
ively, with a very good inter-observer agreement of
k¼ 0.86 (range¼ 0.67–1.00). This is in accordance
with a previous study of 28 patients reporting an accur-
acy of MRI for two observers at 90% and 93%,
respectively, with an inter-observer agreement of
k¼ 0.79 (range¼ 0.56–1.00) (8). Other studies have
shown an accuracy ofMRI in detecting locally advanced
tumors at 75% for both observers with an inter-observer
agreement of k¼ 0.41 (range¼ 0.17–0.64) (55 patients)
(9) and 75% and 71% for the two observers, respectively
(55 patients), with an inter-observer agreement of
k¼ 0.55 (12). The performance of CT in identifying
locally advanced colon cancer has been investigated in
several studies. A recent meta-analysis showed a pooled
sensitivity and speciﬁcity of 77% and 70%, respectively,
for CT in discriminating between T1–T3ab and
T3cd–T4 tumors (a total of 281 patients) (5).
MRI may be superior CT in diﬀerentiating between
early and locally advanced tumors based on the litera-
ture. MRI may be better than CT at discriminating
malignant tissue from the muscularis propria and deﬁn-
ing the extent of tumor inﬁltration. The inability of CT
to diﬀerentiate between desmoplastic and neoplastic
pericolic fat inﬁltration is a well-known problem in
colorectal staging by CT (5). On the other hand, we
only included sigmoid tumors in this study. Staging of
tumors in other sites of the colon may be more diﬃcult
due to peristalsis, breathing artifacts or dislocation of
the bowel during scanning (13). Shrinkage could be a
drawback using pathology as the endpoint. The patho-
logic evaluation of ETI measured after ﬁxation in for-
malin may not correlate precisely with ETI estimated
on MRI. Destruction of the muscularis propria by the
advancing cancer may introduce some subjectivity to
the histological measurement. Shrinkage of the speci-
men in formalin may also be a minor source of
uncertainty.
The overall accuracy of MRI for the two observers
in identifying metastatic lymph nodes was 60% and
66% with a good inter-observer agreement of 0.64
(95% CI¼ 0.39–0.90). Other studies have shown an
accuracy of MRI in detecting metastatic lymph nodes
in the range of 57–73% (8,9,13) and 53% with CT (6).
Table 3. Summary statistics of extramural vascular invasion by
MRI for both observers.
MRI
Observer 1 Observer 2
EMVI* EMVIþy EMVI* EMVIþy
Pathology
EMVI– 21 5 16 10
EMVIþ 3 6 4 5
*No vascular invasion.
yTumor invasion of pericolic vessel.
Observer 1: accuracy¼ 77%, sensitivity¼ 67% (31–91%), specificity¼
81% (60–93%).
Observer 2: accuracy¼ 60%, sensitivity¼ 56% (23–85%), specificity¼
62% (41–79%).
Inter-observer agreement: Kappa¼ 0.52 (0.23–0.80).
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The diagnosis of nodal involvement by imaging
remains a problem in patients with colon cancer since
the lymph node diameter is not a reliable indicator of
nodal metastasis in this disease (14). False-positive
results are caused by benign lymph nodes enlarged
due to inﬂammation. Conversely, false-negative results
are caused by microscopic metastases in lymph nodes
with a normal diameter. Diﬀerent cutoﬀs of lymph
node diameter have been used in order to ﬁnd a balance
between the sensitivity and speciﬁcity in detecting nodal
involvement as illustrated in a CT study where the long-
axis diameter cutoﬀ was lowered to 5mm resulting in
increasing sensitivity (81%) but decreasing speciﬁcity
(26%) (6). DWI may help detection of lymph nodes.
The diﬀerentiation between benign and malignant
lymph nodes using DWI has, however, not proved to
be reliable for rectal cancer, so this diﬀerentiation was
not attempted in this study (15). We instead evaluated
the lymph nodes according to size, heterogenicity in
signal and shape because these criteria may improve
the detection of nodal involvement. However, small
lymph nodes are diﬃcult to evaluate (16). Eﬀorts to
enhance the accuracy of MRI in metastatic lymph
node detection using ultra small superparamagnetic
iron oxide particles have shown promising results
with a 65% sensitivity and 93% speciﬁcity (17), but
the contrast agent is not yet approved and larger stu-
dies are required to elucidate the eﬀect of this drug.
The overall accuracy of MRI for the two observers
in the identiﬁcation of EMVI was 77% and 60% with a
moderate inter-observer agreement of 0.52 (95%
CI¼ 0.23–0.80). Other studies have shown an accuracy
of MRI in identifying EMVI in the range of 69–76%
(8,9,12) and 53% by CT (6).
EMVI is a poor prognostic factor in colon cancer
and increases with increasing ETI (18). As with lymph
nodes imaging has problems detecting microscopic
metastasis and misdiagnosing macroscopic inﬂamma-
tory chances. Correct detection of EMVI by MRI can
be missed at the histological examination (19).
All the measured mean ADC values on MRI were
below 1.0 103 mm2/s. The inter-observer reproduci-
bility of ADC values was excellent (ICC¼ 0.85) in
locally advanced tumors and moderate to good
(ICC¼ 0.60) overall in early and locally advanced
tumors. This is in accordance with a study measuring
ADC values on single slice and solid sample ROIs in
rectal cancer, where the ICCs are in the range of 0.42–
0.65 (20). The inter-observer agreement of ADC meas-
urements in our study might have been better using
whole-volume ROIs, which seem easier reproducible
than single slice ROI measurements (20). The high
level of reproducibility of ADC values found in the
locally advanced tumor is important, since these
values to a higher extent are being used to predict
pathologic response to neoadjuvant radio chemother-
apy of rectal cancer (10). An increase in ADC is pre-
dictive of response to radio chemotherapy in rectal
cancer (21) and future studies are needed to evaluate
whether this is also the case in colon cancer.
To date, very few studies have assessed the reprodu-
cibility of measured ADC in extra-cranial body organs.
Some investigators use volumetric rather than single
ROI-based tumor assessment and some have demon-
strated high variability in the measured ADC. Others
have found less variability in the measured ADC (22).
The majority of investigators found standardized
acquisition protocols to improve reproducibility and
the measured ADC to be dependent on the speciﬁc
anatomy and size of the ROI (22). We used a precise
delineated single slice ROI-based tumor assessment
which is less time-consuming than the whole-volume
ROI method and therefor may be more transmissible
to clinical practice. However, the quantiﬁcation of the
tumors diﬀusion is depending on the image protocol
and experience of the readers (23). Further validation
of ADC reproducibility is warranted and one should
still be careful using ADC values to diﬀerentiate
between normal and cancerous tissues or even between
tumor grades. However, for the assessment of response
to neoadjuvant treatment ADC measures is a promis-
ing tool.
Other limitations of this study include the retrospect-
ive evaluation, a small sample size, and possible selec-
tion bias since not all sigmoid colon cancer patients had
an MRI. Our limited number of patients made it
impossible to perform a subgroup analysis of peritoneal
carcinomatosis. We did not use spasmolytic agents to
reduce motion artifacts, the use of which might have
improved our results. We compared our staging results
with the results from published data on CT staging.
It would have been more valuable with a direct com-
parison on the same material. However, a larger pro-
spective study comparing MRI and CT in staging of
tumors in the whole extent of the colon is under
preparation.
An accurate radiological staging of colon cancer is
crucial to select the patients who may beneﬁt from
neoadjuvant chemotherapy. MRI may have an advan-
tage over CT in identifying patients with locally
advanced colon cancer due to better soft tissue discrim-
ination. Although remaining a challenge MRI seems
more accurate than CT in predicting poor prognostic
factors such as lymph node metastases and EMVI. The
detection of liver metastases is more accurate with MRI
than CT (24) and favors MRI in the preoperative
assessment of colon cancer, but further studies are
warranted.
In conclusion, preoperative MRI was found to reli-
ably identify locally advanced sigmoid colon cancer
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deﬁned as T3cd–T4 tumors and has potential as the
imaging of choice when selecting patients for neoadju-
vant chemotherapy. Initial experience with primary
tumor ADC measurement has been achieved with an
excellent inter-observer agreement in advanced tumors.
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